Tag: Extended-Release Aflibercept
Extended-Release Aflibercept: New Formulation Offering Enhanced Diabetic Retinopathy Control
Pioneering a New Standard in Diabetic Retinopathy Management
Diabetic retinopathy (DR) is a leading cause of vision impairment worldwide. It stems from chronic hyperglycemia, which...
